JXR repurchases 3.23 million shares for HK$7.89 million; 54.46 million shares bought back under existing mandate

Bulletin Express
04/20

Jinxin Fertility Group Limited (JXR) disclosed a Next Day Disclosure Return dated 20 April 2026 detailing its latest share repurchase activity on the Hong Kong Stock Exchange.

• Latest transaction (20 April 2026): 3.23 million ordinary shares were bought back on-market at prices between HK$2.43 and HK$2.45 per share, for a total consideration of HK$7.89 million. All shares are designated for cancellation.

• Cumulative pending cancellation: Including the latest purchase, 14.80 million shares acquired between 27 March and 20 April 2026 remain to be cancelled.

• Share capital: Issued share capital stands at 2.71 billion shares. The repurchased shares have not yet been cancelled, so the issued share count is unchanged.

• Mandate utilisation: The current repurchase mandate, granted on 26 June 2025, authorises buybacks of up to 274.47 million shares. To date, JXR has repurchased 54.46 million shares, equal to 1.98 % of the company’s issued shares at the mandate’s adoption, leaving significant capacity for further purchases.

• Moratorium: In line with Hong Kong listing rules, JXR is restricted from issuing new shares until 20 May 2026, 30 days after the most recent repurchase.

The disclosure confirms that all repurchases complied with Hong Kong Stock Exchange regulations and the terms of the company’s explanatory statement dated 4 June 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10